Using risperidone for Alzheimer's dementia-associated psychosis

Author： McNeal Karleen M Meyer Renee P Lukacs Karen Senseney Anna Mintzer Jacob

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.14, 2008-10, pp. : 2537-2543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Atypical Antipsychotics in the Treatment of Psychosis and Agitation Associated with Dementia

By Madhusoodanan S.

CNS Drugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 135-150

Adis International

Access to resources Recommend Favorite

Efficacy of risperidone in treatment of paranoid symptoms in Alzheimer's disease (A.D.) and vascular dementia (V.D.)

By Wittgens W. Klieser E. Trenckmann U. Beine K.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 351-351

Elsevier

Access to resources Recommend Favorite

Drug-Induced, Dementia-Associated and Non-Dementia, Non-Drug Delirium Hospitalizations in the United States, 1998-2005: An Analysis of the National Inpatient Sample

By Lin Robert Y. Heacock Laura C. Fogel Joyce F.

Drugs & Aging, Vol. 27, Iss. 1, 2010-01 ,pp. : 51-61

Adis International

Access to resources Recommend Favorite

Long-acting injectable risperidone is more effective than oral risperidone for psychosis

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Risperidone for the Treatment of Neuropsychiatric Features in Dementia

By Burns Alistair

Drugs & Aging, Vol. 23, Iss. 11, 2006-01 ,pp. : 887-896

Adis International

Access to resources Recommend Favorite